EPISODE · Jan 22, 2025 · 18 MIN
Datoptamab deruxtecan
from OncoPharm · host John Bossaer
Datopotamab deruxtecan, a newly approved agent for breast cancer, is discussed.
Embed this episode
Ready to play
Datoptamab deruxtecan
0:00
18:49
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of OncoPharm?
This episode is 18 minutes long.
When was this OncoPharm episode published?
This episode was published on January 22, 2025.
Can I download this OncoPharm episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!